Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - OtherRevenue (Gross)
Ratios

Abeona Therapeutics (ABEO) Depreciation & Amortization (IS) (2016 - 2021)

Historic Depreciation & Amortization (IS) for Abeona Therapeutics (ABEO) over the last 11 years, with Q4 2021 value amounting to $807000.0.

  • Abeona Therapeutics' Depreciation & Amortization (IS) fell 392.86% to $807000.0 in Q4 2021 from the same period last year, while for Dec 2021 it was $3.2 million, marking a year-over-year decrease of 2913.21%. This contributed to the annual value of $3.2 million for FY2021, which is 2913.21% down from last year.
  • Latest data reveals that Abeona Therapeutics reported Depreciation & Amortization (IS) of $807000.0 as of Q4 2021, which was down 392.86% from $802000.0 recorded in Q3 2021.
  • Over the past 5 years, Abeona Therapeutics' Depreciation & Amortization (IS) peaked at $2.1 million during Q1 2020, and registered a low of $138000.0 during Q3 2017.
  • Its 5-year average for Depreciation & Amortization (IS) is $814000.0, with a median of $812000.0 in 2021.
  • Per our database at Business Quant, Abeona Therapeutics' Depreciation & Amortization (IS) surged by 85287.36% in 2019 and then crashed by 6043.58% in 2021.
  • Quarter analysis of 5 years shows Abeona Therapeutics' Depreciation & Amortization (IS) stood at $146000.0 in 2017, then surged by 852.74% to $1.4 million in 2018, then soared by 47.88% to $2.1 million in 2019, then tumbled by 59.16% to $840000.0 in 2020, then fell by 3.93% to $807000.0 in 2021.
  • Its last three reported values are $807000.0 in Q4 2021, $802000.0 for Q3 2021, and $824000.0 during Q2 2021.